Search research articles
Contact Us
Filters
Showing results (71-80 of 153) with videos related to
Page
of 16
Sort By:
Clinical and Experimental Dermatology
|
May 12, 2023
Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation
Ted V Jacoby, Maria S Asdourian, Nishi Shah, et al.
JAMA Dermatology
|
April 14, 2021
Association Between Systemic Corticosteroid Treatment for Cutaneous Immune-Related Adverse Events and Survival Outcomes in Patients With Advanced Cancer
Leah L Thompson, Jaewon Yoon, Nira A Krasnow, et al.
Journal of the American Academy of Dermatology
|
July 2, 2022
Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor-induced bullous pemphigoid
Jordan T Said, Jordan Talia, Erin Wei, et al.
Journal of the American Academy of Dermatology
|
August 20, 2025
Glucagon-like peptide-1 receptor agonists mitigate the risk of major adverse cardiovascular events in patients with atopic dermatitis and type 2 diabetes
Natalie Braun, Claire Lin, Natalie Baker, et al.
International Journal of Dermatology
|
March 18, 2026
Effect of Diuretics on Cutaneous Squamous Cell Carcinoma: Clinical and Translational Evidence
Kevin Sheng-Kai Ma, Stefano Sol, Fabiana Boncimino, et al.
Journal for Immunotherapy of Cancer
|
November 9, 2019
Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
Michael S Hughes, Gabriel E Molina, Steven T Chen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 24, 2026
Effect of pre-existing atopic dermatitis on clinical outcomes of immune checkpoint therapy
Natalie Braun, Bryan L Peacker, Natalie Baker, et al.
The British Journal of Dermatology
|
May 29, 2024
Sodium-glucose cotransporter-2 inhibitors in diabetes and inflammatory skin diseases
Chin-Hsuan Shen, Yi-Sun Yang, Irene Tai-Lin Lee, et al.
International Journal of Dermatology
|
November 26, 2024
External validation study of Re-SCORTEN in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
Mike Westmeijer, Joseph Ebriani, Beatrix B Thompson, et al.
The American Journal of Dermatopathology
|
December 10, 2021
Cutaneous Findings of Sporadic, Adult-Onset Neuronal Intranuclear Inclusion Disease
Jakob M T Moran, Katharina Eikermann-Haerter, Otto Rapalino, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 153) with videos related to
Sort By:
Page
of 16
Clinical and Experimental Dermatology
|
May 12, 2023
Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation
Ted V Jacoby, Maria S Asdourian, Nishi Shah, et al.
JAMA Dermatology
|
April 14, 2021
Association Between Systemic Corticosteroid Treatment for Cutaneous Immune-Related Adverse Events and Survival Outcomes in Patients With Advanced Cancer
Leah L Thompson, Jaewon Yoon, Nira A Krasnow, et al.
Journal of the American Academy of Dermatology
|
July 2, 2022
Impact of biologic therapy on cancer outcomes in patients with immune checkpoint inhibitor-induced bullous pemphigoid
Jordan T Said, Jordan Talia, Erin Wei, et al.
Journal of the American Academy of Dermatology
|
August 20, 2025
Glucagon-like peptide-1 receptor agonists mitigate the risk of major adverse cardiovascular events in patients with atopic dermatitis and type 2 diabetes
Natalie Braun, Claire Lin, Natalie Baker, et al.
International Journal of Dermatology
|
March 18, 2026
Effect of Diuretics on Cutaneous Squamous Cell Carcinoma: Clinical and Translational Evidence
Kevin Sheng-Kai Ma, Stefano Sol, Fabiana Boncimino, et al.
Journal for Immunotherapy of Cancer
|
November 9, 2019
Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
Michael S Hughes, Gabriel E Molina, Steven T Chen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 24, 2026
Effect of pre-existing atopic dermatitis on clinical outcomes of immune checkpoint therapy
Natalie Braun, Bryan L Peacker, Natalie Baker, et al.
The British Journal of Dermatology
|
May 29, 2024
Sodium-glucose cotransporter-2 inhibitors in diabetes and inflammatory skin diseases
Chin-Hsuan Shen, Yi-Sun Yang, Irene Tai-Lin Lee, et al.
International Journal of Dermatology
|
November 26, 2024
External validation study of Re-SCORTEN in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis
Mike Westmeijer, Joseph Ebriani, Beatrix B Thompson, et al.
The American Journal of Dermatopathology
|
December 10, 2021
Cutaneous Findings of Sporadic, Adult-Onset Neuronal Intranuclear Inclusion Disease
Jakob M T Moran, Katharina Eikermann-Haerter, Otto Rapalino, et al.
Page
of 16